Brand Description
KENGREAL is an intravenous P2Y12 platelet inhibitor designed for use in high-risk percutaneous coronary interventions (PCI) to reduce the risk of thrombotic events.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|---|---|---|---|---|---|---|---|---|---|---|
| cmhp4x | RBC | $1.80 | 11/7/2025, 5:34:21 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x250 | 7/10 | 863.55 KB | 8540.00 ms |